Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
    Users Online: 136
Home Print this page Email this page Small font size Default font size Increase font size
REVIEW ARTICLE
Year : 2022  |  Volume : 11  |  Issue : 3  |  Page : 159-164

Focused ultrasound and deep brain stimulation for Parkinsonism – Review of literature to investigate tradeoff between safety and efficacy


1 College of Medicine, Taibah University, Madinah, Saudi Arabia
2 Department of Pediatric Hematology/Oncology, King Faisal Special Hospital and Research Center, Riyadh, Saudi Arabia
3 Department of Mechanical and Mechatronics, University of Waterloo, Ontario, Canada
4 Department of Family and Community Medicine, College of Medicine, Taibah University, Madinah, Saudi Arabia

Correspondence Address:
Uthman Alshenqiti
College of Medicine, Taibah University, Madinah
Saudi Arabia
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/sjhs.sjhs_86_22

Rights and Permissions

Parkinsonism is a movement disorder, mostly caused by the neurodegenerative Parkinson's disease (PD), the second most common movement disorder. Its symptoms include rigidity, slow movement, tremor, and disruption of balance. First treatment line is dopamine replacement drugs, and surgery is due when medication fails. Surgery options include deep brain stimulation (DBS), which revolves around implanting impulse generator in the target structure, and magnetic resonance-guided focused ultrasound (MRgFUS), where transcranial sonication ablates certain structures to counter the excitotoxic circuitopathy. This review aims to compare results described in peer-reviewed publications describing DBS and MRgFUS in Parkinsonism in terms of improvement in symptoms and side effects. This study was carried out by searching prominent computerized biomedical databases (PubMed, Web of Science, Cochrane, and EMBASE) to assess and compare the safety and efficacy of MRgFUS and DBS procedures done for the treatment of PD. Most of the published results for each of the two operations are comparable, in tremor and Unified Parkinson's Disease Rating Scale scores, though minimal superiority is shown in the DBS results. The neurological adverse effects are similar between the two types, including mild-to-moderate transient instances of dysarthria and gait disturbances, which are the most common two adverse events, among others. However, DBS has a more severe or significant adverse event profile that includes hemorrhage and infection. Long-term improvement is observed more with DBS which can sustain improvement for up to 5 years. DBS, therefore, tends to better improve Parkinsonism prognosis at the cost of safety. Postoperative complications are less severe in MRgFUS, which can be a safe, efficient alternative procedure for medication-refractory Parkinsonism.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed1195    
    Printed32    
    Emailed0    
    PDF Downloaded174    
    Comments [Add]    

Recommend this journal